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Arrcstin binds to phosphorylavzd rhodopsin in its light-activated form (melarhodopsin II), blocking thcrcby its interaction with the G-protein, 
mmsducin. In this study, WC show thal highly phosphorylatcd forms of inositol compete against the arrcslin-rhodopsin inlcraction. Competition 
curves and direct binding assays with free arrcslin consislcntly yield affinities in the micromolar range; for example, inositol 1.3.4.5-telrakis- 
phospharc (InP,) and inosilol hcxakisphosphalc (InP, bind to arrcstin with dissociation constants of 12pM and 5 PM. respectively. Only a small 
control amount or inosilol phosphates is bound. when arrcstin interacts wilh phosphorylatcd rhodopsin.This argues for a release of bound inositol 
phosphates by imernclion with rhodopsin. Transducin, rhodopsin kinasc, or cyclic GMP phosphodicsterasc arc noi affected by inositol phosphates. 
These observations open a new way 10 purify arrcsiin and to inhibh its imcraction with rhodopsin. Their physiological significance dcscrvcs further 
inscsligalion. 
Signal rransduclion; G-protein; Rhodopsin; Arrcslin; lnositol phosphate 
I. INTRODUCTION 
The rhodopsin/transducin/phosphodiesterase cas- 
cade of the rod is a weli-studied cxamp!e of a receptor/ 
G-protein/effecter system. Absorption of light leads to 
the formation of metarhodopsin II (MN) that activates 
transducin by catalysing GDP/GTP exchange [1,2]. 
Transducin activates a cyclic GMP phosphodiestcrase 
and lowers cytoplasmic cyclic GMP. Since cyclic GMP 
keeps Na+/Ca”- channels open for the influx of these 
ions, the channels close, the cell hyperpolarizes, and the 
Ca” level drops (reviewed in ref. 3). 
Quenching of the light signal occurs at least at three 
points. When metarhodopsin II is phosphorylated by a 
specific kinase (reviewed in ref. 4), it binds a regulatory 
protein, arrcstin, which blocks further activation of the 
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G protein [5]. A protein with analogous function, ,?- 
arrestin, was recently described for the/?-adrenergic sys- 
tem [6]. The G protein is de-activated by hydrolysis of 
bound GTP to GDP. In a third quenching pathway, the 
lowering of calcium stimulates guanylate cyciase via a 
calcium-binding prctein and restores the cyclic GMP 
level (reviewed in ref. [7]). 
Recently, we have found that heparin is a potent 
inhibitor of the arrestin-rhodopsin interaction and that 
heparin and phosphorylated rhodopsin induce the same 
distinctive pattern in the limited proteolysis of arrestin 
[S]. We tested other potential Iigands of arrestin, includ- 
ing sulfonated or phosphorylated analogues of carbo- 
hydrates, nucleotides, and sulfonated or phosphoryla- 
ted inositol derivatives. A digestion pattern similar to 
‘. ’ L.,:-_.l L__..l”.,A ncparur Was oura~r~cu Oiiiji fei @~OSPIIV~J~O~~~ ail;!& 
gues of inositol. 
This finding, the role of inositol phosphates in inver- 
tebrate phototransduction [9] and evidence of the com- 
plete pathway in rods [lo] motivated the present study. 
WC present evidence that arrestin is a soluble receptor 
for inositol phosphates. Binding of the phosphates and 
of phosphorylated metarhodopsin II compete against 
one another. 
2. MATERIALS AND METHODS 
2. I. Rwgctm 
Inosilol phosphalcs were in D-myo conformalion. [inosilol-l- 
‘H(N)]I,3.4,5-Tctrakisphosphatc (I 7 CiImmol) and [inositol-2- 
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FigI. Inhibhion of the intcracrion between melarhodopsin II (MII) 
and arrestin by InP, and other phosphorylated dcrivativcs of inosilol. 
A. Effcc~ of InP, on 111~ stabili!y of metarhodopsin II (MII! in complex 
with arrcslin or rransducin. The records arc the increase in absorption 
al 350 nm (A,,,;,, of MI1 pholoproduct). Undislurbcd inlcraclion of 
hill with arrcslin or transducin leads 10 enhanced MII formalion 
(extra MB). For arresba the cnhancemcnt is inhibited by IPr, (lcli, 
middle), and only lhe control amount of MII is formed. B. Lcvcl of 
extra Ml1 (Ml1 with arrcstin and inositol analogues, minus thecontrol 
MII) as a function of ligimd concentration. The symbols arc: inoshol 
I-phosphauc (InP,). closed square; inositol 1.4.bisphosphatc (InP,), 
open lrianglc; InP,, asterisk; InP,. open circle: I#,. closed triangle; 
and InP,. open square. The lines through the data arc computer fus 
whh hyperbolic functions (cxponcms between 0.8 and I. I ). 
LH(N)]hcxakisphospha~c(12 Ci!mmol) were obtained from NEN (Due 
Porn). lnositol I-phospha~. inoshol I .I-bisphosphatc, InP1, InP,. ino- 
shol 1.2,5,6-b~rakisphosphatc, inoshol 1.4.5,6-tctrukisphosphatc, and 
InP, were purchased from Bochringcr Mannhcim. InP,, and omcr 
chemicals were obtained from Sigma Chemical Cb.. 
Phosphorylatcd rhodopsin was prepared from urea-washed ROS as 
described previously [I I]. Arrestin was prepared from bovine rclinas 
using a modification of rhc previously described method [ 121. 
40 bovine retinas were glass-glass homogenized whh ice-cold IO 
mXi HEPES buffer, pH 7.5. conmining I mM bcnxamidinc and IS 
pg/ml Icupcptin. Soluble proteins wcrc scparaicd by ccmrifuga\ion for 
25 min at 43 700 x 6. The cxtmct was applied lo a I .6 x I4 cm column 
of DEAE-cellulose (Whatmann DE52) which had been cquilibraled 
whh IO mM HEPES, pH 7.5. The column wus washed whh HEPES 
buffer conmining 15 m>l NaCI, at 111~ flow rate 30 ml/h umil absorb. 
NW el 280 nm dropped below 0. I and a major hemoglobin band Wils 
December I99 I 
TABLE I 
Binding of inoshol derivatives to arrcstin 
ZG $l, 
IO2 000 3 400 
3 360 I I20 
I70 57 
38 I4 
134 45 
73 25 
20 
IO : 
IGu were dctcrmincd employing die ‘cxlra Mela II’ asray(Fig. I; 
scclion 2. 
f& values wcrc rslimatcd assuming the following scheme or reactions: 
Ml -- Mll + A --- MII A 
+ InP,, 
AlnP,, 
where A is arrestin. MI and MII is mclarhodopsin I and II. rcspec- 
lively. The equalion for IC,,, derived from the schcmc is ICI:, = ([K,,,l 
W,,, + Ilx[A,,,,,,,-R,,,,:,I)!K,,,1- I I XL whcrc R IS rhodopsm; K,,, 
=[Mll]~[Ml];n’,,~ =[Mll-A]@‘lll]x[A]: ~l,a=[A-lnP,,]![A]x[lnP,,],,,,:,. 
Abbreviations: D-myo-inoshol I-phosphate (InP,); D.niyo-inositol 
I .4-bisphosphalc ( InP1). 
clutcd from the column. Arrcstin Was clutcd by a NaC! gradient (240 
ml 10~1, from 0 to I50 :nM NaCl cornaining 0.5 mM benzamidinc). 
Arrestin was elutcd al aboul 75 mM NaCl as dc~crmincd by SDS- 
PAGE. Fractions containing arrcsnn wcrc applied IO a I x 7 cm 
column of Hcparin-Sepharosc which had been cquilibra!cd with IO 
mM HEPES and IO0 mM NaCI, pH 7.5. The column was vvashcd with 
HEPES buffer containing I50 mM NaCI. at a flow ralc or I2 ml/h umil 
mc absorbance at 280 nm dropped below 0.01. Arrcstin was clumd by 
a InP, gradient (70 ml total from 0 10 8 mM InP,, in 111~ washing 
buffer). Arrcstin was elmed at 2.5pM of InP,# and with a purhy higher 
than 90%. 
In order IO further eliminate conlaminating promins (less Ihan 5%) 
and InP,. arrcstin was briefly dialyzed agrins\ IO mM HEPES buff&-. 
pH 7.5, conmining I00 mM NaCI. Next. arrestin was applied IO a I 
x 3.5 cm column of Hcparin-Scpharosc, equilibrated with IO mM 
HEPES and 100 mM NaCI, pH 7.5. The column wus washed whh 
HEPES buffer comaining 200 mM NaCl (8 ml), at a flow ram of I2 
ml/h. Arrcslin was clutcd by 400 mM NaCI in the HEPES bull&. 
Aboul 4 mg of homogeneous arrcstin wus obtained. All procedures 
wcrc pcrformcd at 5°C. 
Transducin was isolalcd from rod ouwc segments according LO 
Kiihn [l3]. 
Esrnr-.~I//-intcrac~ion with transducin [2] or arrcslin [X,14] slabi- 
lizcs the 380 nm pholoproduct mc\arhodopsin II (MII) aI the cxpensc 
ofits uuuomcric forms Ml and MIII, which absorb in 1hc460-480 nm 
spectral rang. The flash phololysis apparatus mcasurcs 111~ difference 
bctwccn the absorbance changes ai 380 nm (A,,,,, of MII) and 417 nm 
(isosbcsdc point of the Ml/MI1 transhion) [14]. 
Er/rri/ihrirrm dirr/J.si.r WIS pcrformcd using IO mM HEPES buffer, pH 
7.5. containing 100 mM NaCI, essentially as described clscwhcrc [l5]. 
The dialysis cells conmin Spcctrapor I mcmbrancs (molecular weight 
cutoff IO 001)). I30 ~1 of arrcsiin solutions (0. l-l mg/ml) wcrc placed 
in one compartment and I30 ~1 of 2-705 p>l [inoshol-l- 
‘H(N)]l.3,4.5-lclr;~kisphosphatc or 444 PM [inoshol-2-~H(N)]hcxa- 
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Fig.‘. Binding of InP,, lo arrcstin. A. Scatchard plot of equilibrium 
dialysis [12.15].[inositol- ‘-‘H(N)]licxakispllosphatc and arrcstin wcrc 
placed in IWO dilfcrcnt compartments 01’ a dialysis cell and dialyscd 
IO equilibrium as dcscribcd in section 2. B. Gel filtration according to 
rcr. [16]. [inositol-2-‘H(N)]hcxakisphosphateand arrcstin wrc loaded 
on a Supcrosc 6 column as dcscribcd in scclion 2. Protein profile from 
280 nm absorption (open circle), inositol from radioactive counting 
(closed circle). 
0.72 
$ o*54 
T 
3 0.36 
0.16 
kisphosphatc in the other. Dialysis wasconductcd for 50 hat S°C with 
continuous shaking. Controls showed thal the system rcachcd cqui- 
librium. lnositol derivative concentrations were dctcrmincd from spc- 
cilic radioactivity. 
Geljilrrcrriorr-Cicl filtration was carried out accordine to Ackcrs 
[I61 on a Supcrosc 6 column (Pharmacia) equilibrated iith IO mM 
HEPES, pH 7.5. 100 mhl NaCI. in the presence of 0.2pM [inositol- 
I -‘H(N)]l,3.4.5-tctrakisphosphatc or 0.2 phi [inositol-2-‘H(N)]hcxa- 
kisphospatc. 0.24 mg of arrcstin was loaded per run. The protein 
profile was dctcrmincd by the absorption at 280 nm; inositol con-. 
ccntration was dctcrmincd by radioactive counting. 
3. RESULTS 
clopsirl hrerucriow 
Fig. 1 shows original records (A) and competition 
curves (B) for the ‘extra MII’ assay. Under control con- 
ditions, a flash of light forms a small amount of meta- 
rhodopsin II (MI]). Additional MI1 arises from the in- 
teraction of arrestin or transducin with MII. The 
amount of extra MII (MI1 level with arresrin minus 
control) is a stoichiometric measure of the complexes 
formed [ 141. As Fig. 1A shows, only formation of the 
complex with arrestin, but not with transducin, is 
blocked by IP,. All inositol phosphates gradually 
suppress extra-MI1 with increasing concentration (Fig. 
IB), with a potency that increases roughly with the 
degree of phosphorylation. Among the three tested 
isomers of inositol tetrakisphosphate the isomer 
(1,3,4.5) is most effective (data not shown), tri-. di- and 
mono-phosphorylated erivatives of inositol are much 
less effective (Table I). The data for all inositol 
phosphates fit well to linear hyperbolic competition 
curves (lines through the data). 
The MI1 stabilization data are consistent with the 
interpretation that one molecule of inositol phosphate 
P 
0.54 
_P 
3 0.36 
Fig.3. Binding or InP, and InP, to phosphorylatcd mcmbrancs and arrcstin. The expcrimcnts analyst the tract amounts of inositol phosphates that 
bind IO phosphorylatcd mcmbrancs when arrcstin is bound IO cxccss phosphorylatcd photoactivatcd rhodopsin. The sample ofprc-phosphorylatcd 
rhudopsin. iu’rcstin and dilTcrcnt amounls or the inositol phosphalcs was illuminated (light) or incubated in the d;lrk (dark) and ccntrifugcd as 
dcscribcd in section 2. II is seen ltlal the illuminated sample (containing the rhodopsin arrcslin complex) dots IIOI bind more inositol than the dark 
control. 
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interacts with arrestin and competes with phosphorylat- 
ed metarhodopsin II for the same binding site. 
Like transducin, rhodopsin kinase is not inhibited by 
up to 1 mM InP, (nor by InP,, see ref. Palczewski et al. 
1988b); cyclic GMP phosphodiesterase is not inhibited 
either by 250 PM InP, (data not shown). 
3.2. Inosirol phosphates bind to free arres;itl 
The interaction between inositol phosphates and ar- 
restin can be directly monitored by equilibrium dialysis 
and gel filtration. Fig. 2A shows a Scatchard plot of 
equilibrium dialysis data for IP,. One obtains a dissocia- 
tion constant of Ko = 5.5 PM and a number of binding 
sites tt = 1.12 For IP,, the values are 12.5 PM and tt = 
1.02 (dat not shown). These values fit to the Kn’s from 
the competition curves in Fig. 1 (see Table I). 
Elution profiles of gel filtration are shown in Fig. 2B. 
The positive and negative peaks are expected for bind- 
ing of InP, and InPs to arrestin. A comparison of the 
column profiles with the standard proteins bovine 
serum albumin (67 000 Da) and ovalbumin (43 000) 
ensured that arrestin dit not aggregate in the presence 
of the inositols (data not shown). When Heparin-Sepha- 
rose is used as an affinity matrix for arrestin, arrestin 
is the only protein eluted with InP6 (see section 2). This 
argues for an at least partial overlap of the binding sites 
at arrestin for heparin and the inositol phosphates. 
3.3. Inositol phosphates do nor bind to the rhodopsin- 
arresrin complex 
When an excess of pre-phosphorylated metarhodop- 
sin II is formed, more than 90% of the arrestin in the 
sample is bound at ,uM concentration. As shown in Fig. 
3, the amount of InP, and InP, recovered with the mem- 
branes is as small as in the dark control. Together with 
the data of the preceding section, this shows that bound 
inositol phosphates are released when arrestin binds to 
rhodopsin. 
On the other hand, the data show a small, light-in- 
dependent capacity of disc membranes to bind inositol 
derivatives. 
4. DISCUSSION 
Direct binding assays and inhibition of complex for- 
mation between arrestin and phosphorylated active me- 
tarhodopsin II (MII) have shown that arrestin binds 
inositol phosphates with micromolar affinity, The bind- 
ing is specific, and is not even seen with rhodopsin 
kinase which shares with arrestin a high affinity for 
heparin. The binding site of inositol phcsphates appears 
to overlap the binding domain of phosphorylated rho- 
dopsin. Identification of inositol phosphates as specific 
ligands of arrestin, which decouple it from phosphor- 
ylated rhodopsin, provides a simple tool for studying 
arrestin function in the rod cell and simplifies its isola- 
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tion. /l-Arrestin [6] can be expected to be inhibited as 
well. 
Further conclusions will depend on determination of 
the amount of higher inositol phosphates in the rod cell. 
InP,, InPS and InP, are present in ,uM concentration in 
various mammalian cells, including neuronal cell lines 
[17,18]. A receptor for IP6 was recently identified in rat 
brain [19]. Not only IPs but also higher phosphates are 
involved in the control of calcium [20]. 
Arrestin is abundant (100-300 ,uM) in rods [21] and 
the binding of the inositol phosphates (Ko in the 10 ,uM 
range, Table I) is tight enough to complex the accessible 
cellular inositol with arrestin. Since the complex of ar- 
restin with phosphorylated metarhodopsin II is much 
tighter (K,, in the 50 nM range [14]), a change in the 
InsP concentration should not influence the rhodopsin- 
arrestin complex. However, bleaching of a large frac- 
tion of the rhodopsin (3 mM in the rod outer segment) 
could considerably affect the inositol pool. This is the 
condition of bleaching adaptation (see for example ref. 
[22]), a regulation of rod sensitivity that appears to 
bypass the G-protein [23,24]. Whether a regulatory 
pathway exits, which originates from the light-depend- 
ent release of arrestin-bound inositol phosphates, re- 
mains to be investigated. 
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